Hongxue Shi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Transforming Growth Factor

Top Venues

Science translational medicine

Hepatology (Baltimore, Md.)

Immunological reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Mary P Moore, Xiaobo Wang, John Paul Kennelly, Hongxue Shi, Yuki Ishino, Kuniyuki Kano, Junken Aoki, Alessandro Cherubini, Luisa Ronzoni, Xiuqing Guo, Naga P Chalasani, Shareef Khalid, Danish Saleheen, Matthew A Mitsche, Jerome I Rotter, Katherine P Yates, Luca Valenti, Nozomu Kono, Peter Tontonoz, Ira Tabas
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation. Hepatology (Baltimore, Md.) (2024)
Maaike Schilperoort, David Ngai, Santosh R Sukka, Kleopatra Avrampou, Hongxue Shi, Ira Tabas
The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation. Immunological reviews (2023)
Ingmar Mederacke, Aveline Filliol, Silvia Affo, Bindu Nair, Celine Hernandez, Qiuyan Sun, Florian Hamberger, Francesco Brundu, Yu Chen, Aashreya Ravichandra, Peter Huebener, Helena Anke, Hongxue Shi, Raquel A Martínez García de la Torre, James R Smith, Neil Cowan Henderson, Florian W R Vondran, Carla V Rothlin, Heike Bähre, Ira Tabas, Pau Sancho-Bru, Robert F Schwabe
The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver. Science translational medicine 14 (639) (2022)
Hongxue Shi, Xiaobo Wang, Fang Li, Brennan D Gerlach, Arif Yurdagul, Mary P Moore, Sharon Zeldin, Hanrui Zhang, Bishuang Cai, Ze Zheng, Luca Vittorio Valenti, Ira Tabas
CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. Science translational medicine 14 (672) (2022)